Interferon-τ prospects for clinical use in autoimmune disorders

BioDrugs

Volumn 11, Issue 2, 1999, Pages 125-135

  Soos, Jeanne M ^a   Johnson, Howard M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 2; MYELIN BASIC PROTEIN; NEUTRALIZING ANTIBODY; SUPERANTIGEN; TAU INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; DRUG EFFICACY; DRUG STRUCTURE; FETUS RESORPTION; HUMAN; LEUKOPENIA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; WEIGHT REDUCTION;

EID: 0032990788     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199911020-00006     Document Type: Review

References (68)

1. Bazer FW, Johnson HM. Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents. Am J Reprod Immunol 1991; 26: 19-22
2. Johnson HM, Bazer FW, Szente BE, et al. How interferons fight disease. Sci Am 1994; 270: 40-7
3. Pontzer CH, Bazer FB, Johnson HM. Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res 1991; 51: 5304-7
4. Soos JM, Subramian PS, Hobeika AC, et al. The interferon pregnancy recognition hormone, interferon tau, blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 1995; 155: 2747-53
5. Soos JM, Mustafa MG, Subramanian PS, et al. Oral feeding of intereron τ can prevent acute and chronic relapsing forms of experimental allergic encephalomyelitis. J Neuroimmunol 1997; 75: 43-50
6. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990; 8: 579-621
7. Martal J, Lacroix MC, Loudes, C, et al. Trophoblastin, an antiluteolytic protein present in early pregnancy in sheep. J Reprod Fertil 1979; 56: 63-73
8. Godkin JD, Bazer FB, Moffatt J, et al. Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocysts at day 13-21. J Reprod Fertil 1982; 65: 141-50
9. Vallet JL, Bazer FW, Fliss MFV, et al. Effect of ovine conceptus secretory proteins and purified ovine trophoblast protein-1 on interoestrous interval and plasma concentrations of prostaglandin F2alpha and E and of 13,14-dihydro-15-keto prostaglandin F2alpha in cyclic ewes. J Reprod Fertil 1988; 84: 493-504
10. Godkin JD, Bazer FB, Thatcher WW, et al. Proteins released by cultured day 15-16 conceptuses prolong luteal maintenance when introduced into the uterine lumen of cyclic ewes. J Reprod Fertil 1984; 71: 57-64
11. Vallet JL, Bazer FW, Ashworth CJ, et al. Development of a radioimmunoassay for ovine trophoblast protein-1, the antiluteolytic protein from the sheep conceptus. J Endocrinol 1988; 117: R5-R8
12. Flint APF, Sheldrick EL, McCann TJ, et al. Luteal oxytocin: characteristics and control of synchronous episodes ofoxytocin and PGF2alpha secretion at luteolysis in ruminants. Domest Anim Endocrinol 1990; 7: 111-24
13. Mirando MA, Ott TL, Harney JP, et al. Ovine trophoblast protein-one inhibits development of endometrial responsiveness to oxylocin in ewes. Biol Reprod 1990; 43: 1070-8
14. Bazer FW, Spencer TE, Ott TL. Interferon tau: a novel pregnancy recognition signal. Am J Reprod Immunol 1997; 37: 412-20
15. Bartol FF, Roberts RM, Bazer FW, et al. Characterization of proteins produced in vitro by peri-attachment bovine conceptuses. Biol Reprod 1985; 32: 681-93
16. Gnatek GG, Smith LD, Duby RT, et al. Maternal recognition of pregnancy in the goat: effects ofconceptus removal on interestrus intervals and characterization of conceptus protein production during early pregnancy. Biol Reprod 1989; 41: 655-64
17. Liu L, Leaman DW, Roberts RM. The interferon-tau genes of the giraffe, a nonbovid species. J IFN Cytokine Res 1996; 16: 949-51
18. Roberts RM, Cross JC, Leaman DW. Interferons as hormones of pregnancy. Endocrinol Rev 1992; 13: 432-52
19. Imakawa K, Anthony RV, Kazemi M, et al. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 1987; 330: 377-9
20. Stewart HJ, McCann SHE, Northorp AJ, et al. Sheep antiluteolytic interferon: cDNA sequence and analysis of mRNA levels. J Mol Endocrinol 1989; 2: 65-70
21. Klemann SW, Imakawa K, Roberts RM. Sequence variability among ovine trophoblast interferon mRNA. Nucleic Acids Res 1990; 18: 6724
22. Charlier M, Hue D, Boisnard M, et al. Cloning and structural analysis of two distinct families of ovine interferon-alpha genes encoding functional class II and trophoblast (oTP-1) alpha-interferons. Mol Cell Endocrinol 1991; 76: 161-71
23. Jarpe MA, Johnson HM, Bazer FW, et al. Predicted structural motif of IFN tau. Protein Eng 1994; 7: 863-7
24. Pontzer CH, Torres BA, Vallet JL, et al. Antiviral activity of the pregnancy recognition ovine trophoblast protein-1. Biochem Biophys Res Comm 1988; 152: 801-7
25. Mirando MA, Short EC, Geisert RD, et al. Stimulation of 2,5-oligodenylate synthetase activity in sheep endometrium during pregnancy, by intrauterine infusion of oTP-1, and by intramuscular administration of recombinant bovine interferon-alpha1. J Reprod Fertil 1991; 93: 599
26. Dereuddre-Bosquet N, Clayette P, Martin M, et al. Anti-HIV potential of a new interferon, interferon-tau (trophoblastin). J AIDS Human Retrovirol 1996; 11: 241-6
27. Pontzer CH, Yamamoto JK, Bazer FB, et al. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of interferon-tau. J Immunol 1997; 158: 4351-7
28. Soos JM, Johnson HM. Type I interferon inhibition of super-antigen-induced stimulation: implications for the treatment of superantigen associated disease. J IFN Cylokine Res 1995; 15: 39-45
29. Skopets B, Li J, Thatcher WW, et al. Inhibition of lymphocyte proliferation by bovine trophoblast protein-1 (type I trophoblast interferon) and bovine interferon-alpha1. Vet Immunol Immunopathol 1992; 34: 81-96
30. Cross JC, Roberts RM. Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc Natl Acad Sci USA 1991; 88: 3817-21
31. Hansen TR, Kazemi M, Keisler DH, et al. Complex binding of the embryonic interferon, ovine trophoblast protein-1, to endometrial receptors. J IFN Res 1989; 9: 215-25
32. Stewart HJ, McCann SHE, Lamming GE, et al. Evidence for a role for interferon in the maternal recognition of pregnancy. J Reprod Ferlil 1989; 37 Suppl: 127-38
33. Pontzer CH, Ott TL, Bazer FW, et al. Structure/function studies with interferon tau: Evidence for multiple active sites. J IFN Res 1994; 14: 133-41
34. Whaley AE, Reddy Meka CS, Hunt JS, et al. Identification and cellular localization of unique interferon mRNA from human placenta. J Biol Chem 1994; 269: 10864-8
35. Langford MP, Stanton GJ, Johnson HM. Biological effects of staphylococcal enterotoxin on human peripheral lymphocytes. Infect Immun 1978; 22: 62-8
36. Carlsson R, Sjugren HO. Kinetics of IL-2 and interferon production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol 1985; 96: 175-83
37. Johnson HM, Magazine HI. Potent mitogenic activity of staphylococcal enterotoxin A requires induction of IL-2. Int Arch Allergy Appl Immunol 1988; 87: 87-90
38. Bergdoll MS, Crass BA, Reiser RF, et al. A new staphylococcal enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1981; 1: 1071-2
39. Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 1996; 212: 99-109
40. White J, Herman A, Pullen AM, et al. The Vβ specific super-antigen staphylococcal enteroloxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27-35
41. Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988; 140: 2484-8
42. Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 1988; 176: 1697-707
43. Panitch HS, Hirsch RL, Haley AS, et al. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893-5
44. Panitch HS, Hirsch RL, Schindler J, et al. Treatment of multiple sclerosis with gamma inteferon: exacerbations associated with activation of the immune system. Neurology 1987; 37: 1097-102
45. Powell MB, Mitchell D, Lederman J, et al. Lymphotoxin and tumor necrosis factor alpha production by myelin basic protein specific T cell clones correlates with encephalitogenicity. Int Immunol 1990; 2: 539-44
46. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-46
47. Fritz RB, Chou CH, McFarlin DE. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 1983; 130: 1024-6
48. Schiffenbauer J, Johnson HM, Butfiloski E, et al. Staphylococcal enterotoxins reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci 1993; 90: 8543-6
49. Soos JM, Schiffenbauer J, Johnson HM. Treatment of PL/J mice with the superantigen, staphycoccal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol 1993; 43: 39-43
50. Kalman B, Lublin FD, et al. Effects of staphylococcal enterotoxin B on Tcell receptor Vβ utilization and clinical manifestations of experimental allergic encephalomyelitis. J Neuroimmunol 1993; 45: 83-8
51. Soos JM, Hobeika AC, Butfiloski EJ, et al. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-Vβ8-specific superamigen. Proc Natl Acad Sci USA 1995; 92: 6082-6
52. Schiffenbauer J, Soos JM, Johnson HM. The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 1998; 19: 117-20
53. IFNβ Multiple Sclerosis Study Group. Interferon IFNβ-Ib is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double blind, placebo controlled trial. Neurology 1993; 43: 655-61
54. Rudick RA, Goodkin DE, Jacobs LD, et al. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. Neurology 1997; 49: 358-63
55. Weinstock-Guttman B, Ransohoff RM, Kinkel RP, et al. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 1995; 37: 7-15
56. Mujtaba MG, Soos JM, Johnson HM. CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis. J Neuroimmunol 1997; 75: 35-42
57. Mattsson R, Holmdahl R, Scheynius A, et al. Placental MHC class 1 antigen expression is induced in mice following in vivo treatment with recombinant interferon gamma. J Reprod Immunol 1991; 19: 115-29
58. Tezabwala BU, Johnson PM, Rees RC. Inhibition of pregnancy viability in mice following IL-2 administration. Immunology 1989; 67: 115-9
59. Lin H, Mossman TR, Guilbert L, et al. Synthesis of T helper 2 cytokines at the maternal fetal interface. J Immunol 1993; 151: 4562-73
60. Assal-Meliani A, Kinsky R, Mortal J. In vivo immunosuppressin effects of recombinant ovine interferon-tau (trophoblastin): r.oTP (r.oIFN-t) inhibits local GVH reaction in mice (PLN assay), prevents fetal resoptions, and favors embryo survival and implantation in the CBA/J X DBA/2 mice combination. Am J Reprod Immunol 1995; 33: 267-75
61. Chaouat G. Assal-Meliani A, Martal J, et al. IL-10 prevents naturally occurring fetal loss in the CBA X DBA/2 mating combination, and local defect in IL-10 production in this abortion prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995; 154: 4261-8
62. Degre M. Influence of exogenous interferon on the peripheral white blood cell count in mice. Int J Cancer 1974; 14: 699-703
63. Fent K, Zbinden G. Toxicity of interferon and interleukin. Trends Pharmacol Sci 1987; 8: 100-5
64. David M, Larner AC. Activation of transcription factors by interferon-alpha in a cell free system. Science 1992; 257: 813-5
65. Schindler C, Shuai K, Prezioso VR, et al. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257: 813-5
66. Valazquez L, Fellous M, Stark GR, et al. A protein tyrosine kinase in the interferon a/β signaling pathway. Cell 1992; 70: 313-22
67. Ihle JN, Witthuhn BA, Quelle FW, et al. Signaling by the cytokine receptor family: JAKs and STATs. Trends Biol Sci 1994; 19: 222-7
68. Subramaniam PS, Khan SA, Pontzer CH, et al. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci USA 1995; 92: 12270-4